A popular prescription anxiety drug, Clonazepam, is being recalled nationwide due to a potentially life-threatening mistake on the carton. The Pennsylvania-based company, Endo, is expanding its recall of Clonazepam Orally Disintegrating Tablets in 16 lots with doses ranging from 0.125 milligrams to 2 milligrams.
The incorrect drug strength and wrong drug code on the cartons could lead to serious consequences for consumers, including sleepiness, confusion, dizziness, and breathing difficulties, especially for those with respiratory diseases. Endo has not received any reports of problems stemming from the recall thus far.
The initial recall in July was due to an error at a third-party packager, with the product strength listed incorrectly as 0.125 mg instead of 0.25 mg. The correct strength was reflected in the blister strips inside the package. The recalled cartons also list Par Pharmaceutical of New York as the distributor before being acquired by Endo.
Consumers and retailers are advised not to sell or use the affected products, and to contact Endo at (855) 589-1869 or email rxrecalls@inmar.com with any questions. If you believe you have taken an incorrect dose of Clonazepam, it is recommended to consult a physician immediately.
Source
Photo credit nypost.com